Hite Hedge Asset Management Raised By $13.05 Million Its Eqt (EQT) Stake; Nuvasive (NUVA) Sentiment Is 1.34

June 14, 2018 - By Michael Collier

NuVasive, Inc. (NASDAQ:NUVA) Logo

Nuvasive Inc (NUVA) investors sentiment increased to 1.34 in 2018 Q1. It’s up 0.43, from 0.91 in 2017Q4. The ratio has improved, as 126 hedge funds increased or opened new stock positions, while 94 reduced and sold their equity positions in Nuvasive Inc. The hedge funds in our database now own: 51.57 million shares, up from 51.31 million shares in 2017Q4. Also, the number of hedge funds holding Nuvasive Inc in top ten stock positions increased from 1 to 3 for an increase of 2. Sold All: 24 Reduced: 70 Increased: 75 New Position: 51.

Hite Hedge Asset Management Llc increased Eqt Corp (EQT) stake by 137.37% reported in 2018Q1 SEC filing. Hite Hedge Asset Management Llc acquired 277,737 shares as Eqt Corp (EQT)’s stock declined 4.32%. The Hite Hedge Asset Management Llc holds 479,916 shares with $22.80M value, up from 202,179 last quarter. Eqt Corp now has $14.89B valuation. The stock decreased 1.10% or $0.625 during the last trading session, reaching $56.165. About 2.85 million shares traded or 4.74% up from the average. EQT Corporation (NYSE:EQT) has declined 10.80% since June 14, 2017 and is downtrending. It has underperformed by 23.37% the S&P500. Some Historical EQT News: ; 11/05/2018 – EQT Credit and Ardian Private Debt Provide Financing for Hg’s Investment in MediFox; 26/04/2018 – EQT CORP SAYS NEXT STEP ON STRUCTURE IS SPIN OFF OF NEWCO; 11/05/2018 – EQT AB: EQT Credit and Ardian Private Debt provide financing for Hgs investment in MediFox; 26/04/2018 – RICE MIDSTREAM PARTNERS LP – STREAMLINING TRANSACTION IS EXPECTED TO BE IMMEDIATELY ACCRETIVE TO BOTH EQM AND EQGP’S DISTRIBUTABLE CASH FLOW PER UNIT; 27/04/2018 – EQT Infrastructure to Sell lslaLink to Fiera Infrastructure; 16/03/2018 – EQT Midstream Partners Responds to FERC Announcement; 15/03/2018 – EQT CORP – STEVEN SCHLOTTERBECK, PRESIDENT AND CHIEF EXECUTIVE OFFICER, HAS RESIGNED; 17/04/2018 – EQT Corp Presenting at Conference May 17; 23/05/2018 – EQT AB: EQT BUYS ITALIAN ONLINE PRICE COMPARISON PLATFORM; 26/04/2018 – EQT CORP – PERMIAN SALE WILL REDUCE COMPANY’S 2018 PRODUCTION SALES VOLUME GUIDANCE BY 5 BCFE

Among 22 analysts covering EQT Corporation (NYSE:EQT), 15 have Buy rating, 0 Sell and 7 Hold. Therefore 68% are positive. EQT Corporation had 88 analyst reports since July 21, 2015 according to SRatingsIntel. On Thursday, February 25 the stock rating was downgraded by Suntrust Robinson to “Neutral”. The firm has “Hold” rating given on Tuesday, January 12 by Jefferies. The rating was maintained by Cowen & Co on Tuesday, September 12 with “Buy”. Morgan Stanley maintained EQT Corporation (NYSE:EQT) rating on Wednesday, October 18. Morgan Stanley has “Equal-Weight” rating and $64 target. The rating was reinitiated by GMP Securities with “Buy” on Wednesday, September 28. JP Morgan initiated the stock with “Overweight” rating in Wednesday, December 9 report. BMO Capital Markets upgraded EQT Corporation (NYSE:EQT) on Tuesday, June 20 to “Outperform” rating. The rating was maintained by SunTrust on Thursday, October 26 with “Hold”. As per Wednesday, July 5, the company rating was downgraded by RBC Capital Markets. Howard Weil downgraded the shares of EQT in report on Thursday, August 11 to “Sector Perform” rating.

Since January 1, 2018, it had 5 buys, and 0 selling transactions for $292,824 activity. Szydlowski Norman J bought $8,595 worth of stock. Cary A. Bray Jr. also bought $31,761 worth of EQT Corporation (NYSE:EQT) on Monday, January 1. Shares for $204,720 were bought by McNally Robert Joseph.

Investors sentiment decreased to 1.15 in Q1 2018. Its down 1.30, from 2.45 in 2017Q4. It dived, as 62 investors sold EQT shares while 140 reduced holdings. 71 funds opened positions while 161 raised stakes. 221.16 million shares or 2.70% less from 227.29 million shares in 2017Q4 were reported. Teacher Retirement Sys Of Texas reported 0.03% in EQT Corporation (NYSE:EQT). Comml Bank Of Montreal Can owns 234,462 shares for 0.01% of their portfolio. Signaturefd accumulated 0% or 357 shares. Clinton Gp holds 0.03% or 6,132 shares. Conning has 0.01% invested in EQT Corporation (NYSE:EQT). 19,500 are held by Old Mutual Global (Uk) Limited. Goldman Sachs Group has 0.05% invested in EQT Corporation (NYSE:EQT) for 3.80M shares. Assetmark Inc, California-based fund reported 567 shares. Moreover, Stock Yards Savings Bank has 0.06% invested in EQT Corporation (NYSE:EQT). Westpac Bk stated it has 22,154 shares or 0% of all its holdings. Moreover, Centre Asset Management Limited Liability Company has 1.74% invested in EQT Corporation (NYSE:EQT). Voya Investment Mgmt Llc reported 1.71 million shares. Massmutual Tru Fsb Adv has 606 shares for 0% of their portfolio. Moore Cap Limited Partnership holds 711,696 shares. New Mexico Educational Retirement Board invested in 0.04% or 23,327 shares.

Hite Hedge Asset Management Llc decreased Energy Transfer Partners Lp stake by 317,781 shares to 492,347 valued at $7.99 million in 2018Q1. It also reduced Cheniere Energy Partners Lp (NYSEMKT:CQP) stake by 102,165 shares and now owns 74,791 shares. Eqt Midstream Partners Lp (NYSE:EQM) was reduced too.

Consonance Capital Management Lp holds 5.25% of its portfolio in NuVasive, Inc. for 1.10 million shares. Sector Gamma As owns 371,997 shares or 3.5% of their US portfolio. Moreover, Sg Capital Management Llc has 2.52% invested in the company for 251,377 shares. The New York-based Broadfin Capital Llc has invested 2.1% in the stock. Champlain Investment Partners Llc, a Us-based fund reported 3.14 million shares.

The stock increased 2.43% or $1.3 during the last trading session, reaching $54.76. About 662,052 shares traded or 0.60% up from the average. NuVasive, Inc. (NUVA) has declined 33.94% since June 14, 2017 and is downtrending. It has underperformed by 46.51% the S&P500. Some Historical NUVA News: ; 01/05/2018 – NuVasive Sees FY Adj EPS $2.44-Adj EPS $2.47; 22/05/2018 – NuVasive PRECICE STRYDE System Used in First Patient for Stature Lengthening by Intl Limb Lengthening Expert; 02/04/2018 – NuVasive Portfolio Now Includes ALIF Retractor Platform For Lateral And Supine Approaches; 15/05/2018 – Camber Capital Management Buys New 2.3% Position in NuVasive; 01/05/2018 – NUVASIVE SEES FY ADJ EPS $2.44 TO $2.47, EST. $2.46; 01/05/2018 – NuVasive 1Q Loss/Shr 53c; 01/05/2018 – NUVASIVE REITERATED YEAR 2018 GUIDANCE; 26/03/2018 – At NuVasive $NUVA, Newly appointed CFO Rajesh Asarpota now takes over chief accounting officer position from what looks like to be recently terminated Jereme Sylvain (held position for less than 2 years); 15/05/2018 – Alyeska Investment Group LP Exits Position in NuVasive; 22/04/2018 – DJ NuVasive Inc, Inst Holders, 1Q 2018 (NUVA)

Since January 1, 0001, it had 2 insider buys, and 0 insider sales for $593,220 activity.

More news for NuVasive, Inc. (NASDAQ:NUVA) were recently published by: Orthospinenews.com, which released: “NuVasive Launches AttraX Scaffold Biologic And Reports First Clinical Use” on June 12, 2018. Seekingalpha.com‘s article titled: “Premarket analyst action – healthcare” and published on June 01, 2018 is yet another important article.

Analysts await NuVasive, Inc. (NASDAQ:NUVA) to report earnings on July, 26. They expect $0.58 earnings per share, up 26.09% or $0.12 from last year’s $0.46 per share. NUVA’s profit will be $29.73M for 23.60 P/E if the $0.58 EPS becomes a reality. After $0.39 actual earnings per share reported by NuVasive, Inc. for the previous quarter, Wall Street now forecasts 48.72% EPS growth.

NuVasive, Inc., a medical device company, develops and markets minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery. The company has market cap of $2.81 billion. The Company’s products focus on applications for spine fusion surgery, including biologics used for spinal fusion process. It has a 36.51 P/E ratio. The companyÂ’s principal product is Maximum Access Surgery, a minimally-disruptive surgical platform, which includes its software-driven nerve detection and avoidance systems, NVM5, and intraoperative monitoring services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics.

NuVasive, Inc. (NASDAQ:NUVA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Michael Collier

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: